November 11, 2025 · Form 4 insider transaction
Henderson Jane sold 1,000 shares of Apogee Therapeutics, Inc. at $60.00 per share, a transaction worth $60.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.